Adverum Biotechnologies (ADVM) Misses Q3 EPS by 130c

Adverum Biotechnologies (NASDAQ: ADVM) reported Q3 EPS of ($1.30). Revenue for the quarter came in at $1 million.

For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• KeyCorp (KEY) files for 158.72M share offering by selling stockholders
• Avis Budget Group reaches $650M settlement with Pentwater Capital